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1. Introduction 
It is now well-established that the methylated 
nucleosides in tRNA are formed by the action of 
enzymes transferring methyl groups to preformed 
nucleic acid [ 1, 21 . Furthermore, this reaction is 
species-specific and enzymes from mammalian tissues 
are known to be able to incorporate additional methyl 
groups into tRNA from yeast and bacteria [l-6] . 
Extracts prepared from rat liver produce at least 7 
methylated bases when acting on tRNA from E. coli 
in the presence of polyamines or NH; [3,4]. The use 
of purified tRNA preparations as substrates for 
methylation may produce a much simpler pattern of 
methylated products and permit detailed analysis of 
methylation reactions [5-71. This paper describes the 
methylation of tRNA** from brewers yeast by rat 
liver methylases. It was found that the product of this 
reaction was almost exclusively N2 -methylguanine 
and the site of methylation was the guanosine residue 
at position 26 from the 5’-OH end of this tRNA. 
2. Methods 
Sadenosyl-L-Me- 14C-methionine (50-60 mCi/ 
mmole) was purchased from The Radiochemical 
Centre, Amersham, Bucks,, England. The methylated 
bases and nucleosides used as markers for chromato- 
graphy were obtained from Sigma Chemical Company, 
London and the Cycle Chemical Company, California, 
USA. DEAE-cellulose used was Cellex-D from Bio-Rad 
Laboratories, Richmond, California, USA. DEAE- 
Sephadex A-25 was purchased from Pharmacia, 
Uppsala, Sweden. Purified tRNAASp from brewers 
yeast was a generous gift from Dr. I. Gillam and Prof. 
G.M. Tener, Univ. of British Columbia, Canada. The 
preparation was at least 95% pure tRNAASP [8] . 
The preparation of rat liver tRNA methylase, the 
assay of methylase activity and the determination of 
the methylated bases produced in this reaction were 
as previously described [3, 71 . The preparation used 
as a source of tRNA methylases in the present experi- 
ments was the crude ammonium sulphate precipitate. 
The labelled, methylated tRNAASp was digested with 
pancreatic ribonuclease or ribonuclease T, (Sigma 
Chemical Company, London) and the oligonucleotides 
produced were fractionated on columns of DEAE- 
cellulose or DEAE-Sephadex respectively, in the 
presence of 7 M urea, 0.02 M TrisHCl, pH 7.5 and a 
gradient of NaCl according to published methods 
[9-l 11. Samples of 1 ml of the fractions from the 
column eluate were assayed for radioactivity in the 
presence of 15 ml of a mixture of 2 parts (by volume) 
of 0.6% (w/v) 2,5-diphenyloxazole in toluene to 1 part 
of Triton-X100. The efficiency of counting for 14C 
was about 60%. 
3. Results and discussion 
The methylation of heterogenous preparations of 
tRNA from E. coli by rat liver extracts proceeds at a 
limited rate in the presence of Mg’+ but is greatly 
increased by the addition of polyamines or a high 
concentration of NH: [3, 121 . Similar results to those 
previously published are shown in table 1 which also 
shows that the liver extracts catalysed the methylation 
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Table 1 Table 2 
Methylation of tRNA*sP and unfractionated tRNA in the 
presence of various cations. 
Methylated bases present in tRNAAsP after methylation by 
rat liver enzymes in vitro. 
Cation added 
Methylation of tRNA 
(pmoles/lS min/mg protein) 
Unfractionated tRNA tRNAAsP 
2 mM Mg2+ 32 31 
0.3 M NH; 155 28 
15 mM Putrescine 150 25 
1.5 mM Spermidine 136 22 
The assay medium contained 10 Mmoles Tris-HCl, pH 8.6, 
5 nmoles S-adenosyl-L-Me- 14C-methionine (50 mCi/mmole), 
about 0.5 mg liver protein, the cation cont. shown and either 
200 pmoles yeast tRNAAsP or 50 fig tRNA from E. coli K 12 
(sub-methylated) in a total volume of 0.1 ml. 
of purified yeast tRNAASp but in this case the rate of preparation. Thus although enzymes capable of pro- 
reaction was approximately the same whether Mg’+, ducing at least 7 methylated bases (1-methyladenine, 
NH: or polyamines were added. Analysis of the 5.methylcytosine, IV*-methylguanine, N*,N*- 
methylated bases labelled after incubation of tRNAASP dimethylguanine, l-methylguanine, 7.methylguanine 
with S-adenosyl-L-Me- 14C-methionine and rat liver and S-methyluracil) are present in the rat liver extracts 
extracts revealed that 96% of the incorporated radio- used as source of methylases [3,4] only the enzyme(s) 
activity was present in IV*-methylguanine (table 2). forming N* -methylguanine recognises a suitable site 
The remainder was equally distributed between for methylation in yeast tRNAASp. The finding that 
5methylcytosine and 1-methyladenine and could well this reaction proceeds equally well in the presence of 
be due to methylation of impurities in the tRNAASP Mg*+ as in the presence of the other cations which 
Methylated Base 
~- 
1-Methyladenine 
N *-Methylguanine 
5-Methylcytosine 
Radioactivity present 
(dpm) (% total incorporation) 
171 2 
7905 96 
148 2 
tRNAASP was methylated as described in table 1 in a 
scaled-up reaction mixture of total volume 0.5 ml. The cation 
present was 0.25 M NHf. After incubation at 37” for 15 min 
the tRNA was re-isolated and the methylated bases which had 
been labelled analysed as previously described [ 3, 71. The 
total radioactivity present in the isolated tRNA was 8,286 dpm 
and 99% of this was accounted for in the products shown. 
1 1 
100 300 ’ 5oll 
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Fig. 1. DEAE-Sephadex chromatography of ribonuclease Tr 
digest of 14C-methylated tRNAAsP. tRNAAsP was methylated 
as described in table 1, added to 0.5 mg of E. coli tRNA and 
digested with 50 units of ribonuclease Tr at 37” for 6 hr. The 
digest was applied to a column (80 cm X 1 cm) of DEAE 
Sephadex A-25, the column washed with 50 ml of 20 mM 
Tris-HCl, pH 7.5, 7 M urea and the oligonucleotides then 
separated by elution with a gradient of 0.1-0.45 M NaCl in 
0 
ml”0 Effluent 200 
Fig. 2. DEAE-cellulose chromatography of 14C-methylated 
tRNAAsP digested with pancreatic and Tr ribonuclease. 
Methylated tRNAAsP and carrier tRNA (fig. 1) was digested 
with 50 units ribonuclease Tr and 23 units pancreatic ribo- 
nuclease at 37” for 6 hr. The digest was then chromatographed 
on a colirmn (60 cm X 1 cm) of DEAE-celhrlose with a linear 
gradient of 0.1-0.45 M NaCl in 7 M urea, 20 mM Tris-HCl, 
this buffer. pH 7.5 as described above. 
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Fig. 3. DUE-cellulose chromatography of pancreatic ribonuclease digest of 14C-methylated tRNAAsP. Methylated tRNAASp 
(and carrier tRNA) was digested with 23 units of pancreatic ribonuclease for 6 hr at 37” and the digest chromatographed as 
described for fig. 2. 
stimulate tRNA methylases is in agreement with the 
data of Leboy [4] that Mg’+ supported the formation 
of methylated guanines at rates comparable to those 
found in the presence of polyamines or NH: whereas 
the formation of other methylated bases was much 
greater when the latter compounds replaced Mg*+ in 
the assay medium. It should be noted that the results 
shown in tahle 2 which indicate that N * -methyl- 
guanine was virtually the only product formed by liver 
extracts acting on tRNAASP were obtained following 
methylation of the tRNA in the presence of NH: 
which would allow the formation of other methylated 
bases if suitable sites for methylation were present. 
The site within the nucleotide sequence of 
tRNAASP at which N2-methylguanine was produced 
by rat liver extracts was investigated by digesting the 
r4C-methylated-tRNAASP with pancreatic ribonuclease 
and ribonuclease T, and then isolating the labelled 
oligonucleotides produced by chromatography on 
DEAE-cellulose or DEAE-Sephadex [9- 1 l] . As shown 
in fig. 1 the labelled N2 -methylguanine was found to 
be present in a tetranucleotide following treatment 
with ribonuclease T, suggesting that the sequence 
methylated was GpXpXpXp2MeGp (where X 
represents a nucleoside not attacked by ribonuclease 
T,). When the labelled tRNAASP or this tetranucleotide 
were treated with pancreatic ribonuclease and ribo- 
nuclease T, the labelled N2 -methylguanosine was 
liberated as a mononucleotide suggesting that the base 
preceeding the methylated guanine was a pyrimidine 
(fig. 2). Treatment of the methylated tRNAAsp with 
pancreatic ribonuclease alone liberated another 
tetranucleotide containing the radioactivity (fig. 3) 
suggesting that the N2-methylguanosine was present 
as one of the purines of the sequence 
PypPupPupPupPyp (where Py is a pyrimidine and Pu 
is a purine). Combining the information given above 
suggests that the N2 -methylguanosine was present in 
an oligonucleotide of composition 
GpXpXpPyp2MeGpPupPupPyp. A sequence which 
could be methylated to produce such an oligonucleo- 
tide is indeed present in the total nucleotide sequence 
of tRNAASP from brewers yeast [ 131. This sequence 
occurs from residue 22 to residue 29 from the 5’-OH 
end of tRNAASP and is GpApApUpGpGpGpCp. The 
data therefore strongly suggest hat the site of forma- 
tion of N2-methylguanosine by rat liver enzymes acting 
on yeast tRNAASP was the guanosine residue at posi- 
tion 26 of the molecule. This residue occupies the 
position between the stem of the dihydrouridine loop 
and the anticodon loop. This position within the 
tRNA molecule is known to be occupied by the 
methylated nucleoside, N2, N2 -dimethylguanosine in 
tRNATyr, tRNAne, tRNAPhe, tRNAAla and tRNASer 
from yeast, tRNAPhe from wheat and tRNASe’ from 
rat liver [ 141. N2 -methylguanosine is also produced 
at a similar position in E. coli tRNAmet by enzymes 
from rat liver [6] and from rat kidney and mouse 
colon (Pegg, unpublished observations) but in this 
case the sequence methylated is UpCpGpUpCp. It is 
not clear why the methylation in vitro by mammalian 
enzymes proceeds only to the extent of the mono- 
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methyl derivative but it may be that there is a greater 
specificity for a particular nucleotide sequence for the 
second methyl group to be added (either by the same 
enzyme or a different methylase [ 151) since 
N*, N*-dimethylguanosine in known tRNA sequences 
is always preceded by the dinucleotide GpCp and is 
followed by C, \k or A [14]. 
It is clear from the results of this study and from 
previous investigations of the specificity of tRNA 
methylases [6, 14, 161 that these enzymes attack 
particular sites within the tRNA molecule which are 
defined by the structure of the molecule as well as by 
the sequence of nucleotides around the methylatable 
site. The sequence Up2MeGpGp contains the 
methylated base found when tRNAASP is methylated 
by liver enzymes but the sequence UpGpGp occurring 
at residues 18-20 in the dihydrouridine loop of 
tRNAfMef from E. coli and at residues 41-43 in the 
anticodon arm of yeast tRNAPhe are not methylated 
by rat liver enzymes ([6] ; Pegg, unpublished observa- 
tions). However, although certain methylated bases 
occur at unique sites within the tRNA molecules which 
have been sequenced [ 141, these sites cannot invariably 
be methylated by mammalian enzymes when occupied 
by the relevant unmodified base. Thus although the 
first nucleoside of the dihydrouridine arm is 
N* -methylguanosine in a number of tRNAs the 
guanosine residue at this site in tRNAASp and 
tRNAmef is not methylated by liver extracts. 
Similarly a guanosine between the stems of the anti- 
codon arm and the GTW arm of many tRNAs which 
do not have the extra arm in this region is often 
modified to 7-methylguanosine [ 141 but tRNAAsP is 
not methylated by liver enzymes at this position. 
The formation of 1-methyladenosine when the rat 
liver extract employed as a source of methylases in 
these studies was incubated with tRNAGIU, tRNAfMet 
and tRNAp from E. coli proceeded at a rate at least 
60 times greater than when yeast tRNAASP was added 
and the formation of I-methyladenosine when the 
latter tRNA was a substrate for methylation was so 
low that it could be accounted for by the presence of 
other tRNAs as impurities in the tRNAASP preparation. 
However, the sequence PypAplMeApUp which could 
be produced by methylation of tRNAASp at the 
second nucleoside after the Tp\kpCp sequence (the 
site at which I-methyladenosine is uniquely found in 
tRNAs [ 141) is known to occur in rat liver tRNA and 
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to be formed by the action of rat liver methylases on 
unfractionated yeast tRNA [ 14, 161 . The reason why 
this reaction does not in fact occur may have some 
relevance to the important question posed by 
Staehelin [ 141 as to why some tRNAs are modified 
by methylation in viva but others are not, even 
though enzymes capable of carrying out the analogous 
reaction on other tRNAs are present within the cell. 
The possibility of the existence of tRNA-specific 
inhibitors of tRNA methylases should not be ignored 
in this respect [ 171 and further studies of the 
methylation of tRNAAsp by enzyme extracts more 
extensively purified from normal and neoplastic tissues 
would be of interest. 
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